Reuters logo
BRIEF-Newlink Genetics Corp says it entered into a controlled equity offering(SM)sales agreement with Cantor Fitzgerald & Co
November 29, 2016 / 10:00 PM / a year ago

BRIEF-Newlink Genetics Corp says it entered into a controlled equity offering(SM)sales agreement with Cantor Fitzgerald & Co

Nov 29 (Reuters) - Newlink Genetics Corp

* Newlink Genetics Corp says on Nov 29, 2016 co entered into a controlled equity offering(SM)sales agreement with Cantor Fitzgerald & Co-SEC filing

* Newlink Genetics - May offer and sell, through Cantor, shares of co’s stock par value $0.01 per share, aggregate offering price of up to $40.0 million

* Will pay Cantor a commission rate of up to 3.0% of aggregate gross proceeds from each sale of shares Source text: [bit.ly/2ggV9u7] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below